Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
In Vivo Contract Research Organization Market Revenue Growth Supported By A CAGR Of 7.77% Through 2030
The market for in vivo contract research organizations has experienced robust expansion lately, projecting a rise from $5.23 billion in 2025 to $5.68 billion in 2026, reflecting a compound annual growth rate of 8.6%. This upward trajectory during the past period is attributable to heightened pharmaceutical research and development expenditures, the broadening of biotechnology portfolios, the increasing intricate nature of drug development processes, elevated regulatory demands for preclinical information, and the accessibility of sophisticated animal models.
The market for contract research organizations specializing in in vivo studies anticipates a significant expansion over the upcoming years, projecting a rise to $7.77 billion by the year 2030, underpinned by a compound annual growth rate of 8.1%. This anticipated ascent is fueled by several key factors, including a heightened need for accelerated drug development schedules, a greater utilization of sophisticated in vivo models for disease research, the burgeoning scope of investigations into oncology and rare diseases, the increasing integration of artificial intelligence in preclinical data analysis, and more stringent regulatory oversight concerning safety information. Furthermore, several prominent trends are expected to shape this market during the forecast period, such as a greater tendency for companies to outsource their preclinical research endeavors, an elevated requirement for highly specific disease models, a broader acceptance of toxicology studies adhering to Good Laboratory Practice (GLP) standards, the development of more comprehensive preclinical service packages, and a magnified emphasis on ensuring the caliber and replicability of research data.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25790&type=smp
In Vivo Contract Research Organization Market Development Factors: Which Trends Are Supporting Demand?
The increasing emphasis on personalized medicine is anticipated to fuel the expansion of the in vivo contract research organization sector. This approach to healthcare customizes treatment and preventative measures based on an individual’s genetic predispositions, habits, and surroundings to enhance health results. The heightened attention to personalized medicine stems from the greater availability and lower cost of genetic sequencing technologies, which facilitates more precise pinpointing of genetic alterations. This leads to the development of bespoke treatments that improve patient results and minimize trial-and-error procedures. Consequently, the demand within the in vivo CRO market is escalating as specialized preclinical investigations utilizing particular animal models are required to assess targeted therapies and their impact on unique genetic makeups, directly spurred by the trend toward personalized medicine. Evidence of this trend is seen in February 2024, with the Personalized Medicine Coalition (PMC) reporting that the FDA sanctioned 16 new personalized treatments in 2023, a significant increase from the six approved in 2022, marking the fourth consecutive year that personalized medicines represented over a third of all novel drug approvals by the U.S. Food and Drug Administration (FDA). Thus, the burgeoning interest in personalized medicine is a key driver for the growth of the in vivo contract research organization market.
In Vivo Contract Research Organization Market Segment Analysis Highlighting Growth Areas
The in vivo contract research organization market covered in this report is segmented –
1) By Type: Rodent Based, Non-Rodent Based
2) By Type Of Service: Translational And IND-Enabling In Vivo Studies, Preclinical Services, Post-Approval Nonclinical Safety And Mechanistic Studies
3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice
4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies
Subsegments:
1) By Rodent-Based: Mice Models, Rat Models, Genetically Engineered Rodents, Immunodeficient Rodents, Humanized Rodents
2) By Non-Rodent-Based: Canine Models, Non-Human Primate Models, Swine Models, Rabbit Models, Zebrafish Models
In Vivo Contract Research Organization Market Transformation Trends: Which Innovations Are Driving Change?
Leading players within the in vivo contract research organization sector are prioritizing the creation of novel approaches, including sophisticated incubator programs for advanced therapies, with the aim of expediting the progression of cutting-edge treatments and facilitating foundational clinical investigations. These advanced therapy incubator programs represent targeted endeavors established to assist emerging biotechnology firms by furnishing them with essential resources, expert guidance, and the necessary facilities to expedite the advancement of groundbreaking treatments like gene, cell, and RNA therapies. As an illustration, in April 2025, Charles River Laboratories International Inc., a corporate entity headquartered in the United States, initiated its inaugural group for an advanced therapy incubator program. This forward-thinking program is structured to provide assistance to early-stage biotechnology ventures concentrating on the development of next-generation therapeutic modalities. Participants in this program are afforded opportunities to leverage Charles River’s scientific acumen, its cutting-edge laboratory facilities, and tailored in vivo models, thereby empowering them to quickly produce initial supporting data. Furthermore, the program offers a practical preclinical environment for the validation of potential therapeutic agents, contributing to a reduction in the timeframe required to reach clinical trials and enhancing the probability of achieving regulatory approval. This strategic effort serves as a vital conduit between scientific discovery and clinical application, significantly contributing to the progress of the advanced therapeutics landscape.
In Vivo Contract Research Organization Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the in vivo contract research organization market are Thermo Fisher Scientific Inc, Labcorp Drug Development Inc, Eurofins Scientific SE, WuXi AppTec, Charles River Laboratories International Inc, Evotec SE, GemPharmatech Co Ltd, BIOQUAL Inc, Crown Bioscience Inc, PsychoGenics Inc, Janvier Labs SAS, Taconic Bioscience Inc, Xentech SAS, Altogen Labs Inc, AniLocus Inc, Pharmaron Beijing Co Ltd, Southern Research Institute, SRI International, Envigo RMS LLC, Horizon Discovery Group plc, Inotiv Inc, GenScript ProBio
Access The Complete In Vivo Contract Research Organization Market Report:
In Vivo Contract Research Organization Market Geographic Landscape: Which Region Dominates Industry Growth?
North Americawas the largest region in the in vivo contract research organization market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model